American Invest Hub
  • Politics
  • Investing
  • Business
  • Latest News

American Invest Hub

  • Politics
  • Investing
  • Business
  • Latest News
Investing

CVS Health stock price has crashed: buy this dip

by admin December 17, 2024
December 17, 2024
CVS Health stock price has crashed: buy this dip

CVS Health (CVS) stock price continued its strong downward trend as the company’s woes accelerated. Most recently, it has dropped in the last three consecutive weeks, moving to a low of $46.60, its lowest level since March 2020. It has plunged by over 54% from its highest level in 2022, bringing its market cap to over $62 billion, lower than the $67 billion it spent to acquire Aetna.

Why is CVS falling apart?

CVS Health and other companies in the industry like Walgreens Boots Alliance and Rite Aid are going through a rough time. 

While CVS Health’s top-line revenue is growing, its bottom line has continued to deteriorate. Its revenue has jumped from over $255.7 billion in 2019 to over $367 billion in the trailing twelve months. 

CVS’s net profit in the TTM has moved to $5.01 billion, down from $8.3 billion in the last financial year.

Recently, however, the results showed that CVS Health’s revenue rose from over $89 billion and $95.4 billion. This revenue rose even as its products revenue fell from $61.29 billion to $59.6 billion.

CVS Health’s bottom line plunged, with the net income falling from $2.26 billion to $87 billion, mostly because of the rising restructuring charges. 

CVS Health stock also plunged after Donald Trump warned that he would do away with Pharmacy Benefit Manager (PBM) in a bid to lower drug prices. This is notable since CVS owns Caremark, which is a leading player in the industry. 

Still, the reality is that a US president does not have a lot of power to do that since it would need to pass both in Senate and the House of Representatives. In a recent note, the Pharmaceutical Care Management Association argues that doing that would lead to higher costs. 

CVS Health has also seen substantial competition from companies like Walmart, Target, and even Amazon. It has also experienced substantial costs as wages rise.

Therefore, CVS is working to turn its business around and is even considering splitting Aetna, a company it acquired in a $67 billion deal.

All this has left CVS Health being a cheap company, with a forward P/E ratio of 9.30, lower than the sector median of 20.7 and the S&P 500 index’s 22. This means that CVS may stage a strong comeback next year.

Read more: Here’s why the CVS Health stock price may rebound in 2025

CVS Health stock price analysis

The weekly chart shows that the CVS Health share price has been in a strong bearish trend in the past few years. It has dropped from a high of $101.63 in 2022 to a low of $46.60. The stock has formed a series of lower lows and lower highs.

Most recently, the stock has dropped below the key support at $51.66, its lowest point in March 2024. By moving below that level is important because it invalidated the double-bottom pattern, a popular bullish sign.

The stock has moved below the 50-week and 200-week Exponential Moving Averages (EMA), a sign that bears are in control. Also, the Relative Strength Index (RSI) and the MACD indicators have all pointed downwards.

Therefore, technicals suggest that the CVS Health share price will continue falling in the near term. If this happens, the stock will continue falling and reach a low of $43.23, its lowest level in April 2019. A break below that level will point to more downsides, potentially to the next key support at $40. 

On the flip side, a move above the key resistance level at $51.66, its lowest point on May 28, will invalidate the bearish view as it signals that there are more upside. 

Read more: Why CVS Health stock could appreciate 35% from here

The post CVS Health stock price has crashed: buy this dip appeared first on Invezz

0
FacebookTwitterGoogle +Pinterest
previous post
Indian markets update, Dec 17: Nifty 50 slips below 24,500; Sensex tumbles 600 points
next post
JEPQ and QYLD ETFs outlook for 2025: are they good buys?

Related Posts

Gareth Soloway: Gold and Silver Price Targets, Next...

April 18, 2024

Canada Nickel Company’s NetZero Metals Intends to Develop...

February 9, 2024

How to Invest in Technology (Updated 2024)

March 9, 2024

Ora Gold: Advanced Gold Exploration Company with a...

June 17, 2024

Gold price forecast: no end in sight for...

September 25, 2024

Chris Vermeulen: Bullish on Gold, Silver and Miners,...

July 16, 2024

Lithium and Niobium Anomalies Defined at Mt Gordon

May 22, 2024

Here’s why the DAX index surged to ATH...

September 27, 2024

Drilling Commences at Butcherbird Targeting Reserve Extension to...

May 15, 2024

Bitcoin Well Announces Instant Buy in the USA...

March 13, 2024

    Stay updated with the latest news, exclusive offers, and special promotions. Sign up now and be the first to know! As a member, you'll receive curated content, insider tips, and invitations to exclusive events. Don't miss out on being part of something special.


    By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

    Latest News

    • Interview: Strategic location gives Brazil Potash cost advantage in domestic fertiliser market, says CEO Matt Simpson

      June 1, 2025
    • Canada’s Q1 GDP expands by 2.2%, driven by exports spike ahead of potential US tariffs

      June 1, 2025
    • President Trump to host farewell for Elon Musk as DOGE leader steps away

      June 1, 2025
    • UK’s digital banks face divergent fortunes: Starling stumbles, Monzo and Revolut soars

      June 1, 2025
    • Trump wants Apple to shift iPhone production from India to the US: here’s what it means

      May 18, 2025

    Categories

    • Business (3,022)
    • Investing (2,459)
    • Latest News (1,994)
    • Politics (1,530)
    • About us
    • Contact us
    • Privacy Policy
    • Terms & Conditions

    Disclaimer: americaninvesthub.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

    Copyright © 2025 americaninvesthub.com | All Rights Reserved